Pfizer counsels on early cancer detection, prevention


Pfizer has advised members of society to pay attention to early detection of cancer, help friends and families by encouraging regular self-examination and conversations with doctors.

This was disclosed at Pfizer’s virtual Media Roundtable to commemorate Breast Cancer Awareness Month.

At the Media Roundtable, healthcare practitioners were also encouraged to employ technologies in their respective approvals to have open conversations and support patients.

A Medical Director, East and Anglo West Africa, Kodjo Soroh, said, “Oncology remains a key therapeutic field for Pfizer in which we are working to deliver medical breakthroughs that have the potential to change patients’ lives across the region significantly and we are proud of these achievements, and we thank our media members, colleagues, HCPs and everyone for this event.”


A Consultant Clinical and Radiation Oncologist, NSIA-LUTH Cancer Center, Lagos University Teaching Hospital, Lagos, Nigeria, Dr Adewumi Alabi, stated that there was a high importance of clinical research in breast cancer care.

He said, “The importance of clinical research in breast cancer care cannot be overemphasised. These forums are critical as they allow us to share our best insights and findings that can support patients in winning the battle against cancer.

“Breast cancer itself is one of the deadliest diseases with a high prevalence in the area. On a positive note, we now have evidence-based updates and real-world data showing the efficacy of prescriptions in the management of HR+ HER2- mBC patients.”

The Director, National Centre for Radiotherapy Oncology & Nuclear Medicine, Korle-bu Teaching Hospital, Accra, Ghana, Dr Joel Yarney, noted that the transformative impact of science on breast cancer was evident within the breast cancer community.

“While we’ve made a meaningful change for those living with this disease, our work is far from finished. It is crucial for patients who have been diagnosed with breast cancer or even metastatic breast cancer to have the right information and expectations.

“It is our duty to encourage patients to have open conversations with their healthcare teams to understand how they can be supported and how they can participate in their own caretaking an active role in their treatment can help them feel empowered in making the best decisions for themselves,” he added.

Share your story or advertise with us: Whatsapp: +2347068606071 Email:


Please enter your comment!
Please enter your name here